History
2009
John Parker founds the Implant System Team at Data61, formerly NICTA.
2010
1st Evoked Compound Action Potential (ECAP) measured from a spinal cord of a sheep.
2011
1st ECAP measured from the spinal cord in a human.
2012
Spinal cord activation correlated to stimulation current.
2013
1st external Closed-Loop (CL) stimulator developed.
Saluda Medical Pty Ltd is founded.
2014
1st measured ECAP variation from physiological function and movement.
Panorama (US): Prospective, Multicentre, Randomised, Double-Blinded, Crossover Feasibility Study (n=22).
2015
1st fully-implantable Closed-Loop Spinal Cord Stimulation (CL-SCS) system is developed.
1st implant in the Avalon Study (AUS): Prospective, Multicentre, Open-Label Clinical Study.
2017
1st implant of Evoke (US): Prospective, Multicentre, Randomised, Controlled, Double-Blinded, Pivotal IDE Clinical Study.
Initial long-term results of Avalon published in Neuromodulation.3
2018
Evoke Pivotal Study enrollment complete.
2019
Evoke® closed-loop SCS System receives CE mark.
1st commercial implants of Evoke closed-loop SCS system in Europe
Long-term results of Evoke Pivotal Study published in Lancet Neurology.4